Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AmylyxPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AmylyxPharma
-
Welcome to the team as Amylyx' CFO, Jeff Trigilio! Jeff's leadership and financial acumen will be essential as we continue our mission to develop new treatments for
#ALS and#Alzheimer's disease and bring them to patients and families as rapidly as we can. https://bwnews.pr/2tssHym pic.twitter.com/UIWR0wP2aQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amylyx proslijedio/la je Tweet
"I believe that the problems we face are our opportunity and define our human purpose." Former
@Saints player and ALS champion@SteveGleason accepted the Congressional Gold Medal yesterday and delivered a powerful message we can all get behind
@NBCNewspic.twitter.com/AnsY8yUZDTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to be among
@BosBizJournal drug makers to watch. Here’s to making 2020 a transformative year for those impacted by neurodegenerative diseases#ALS#Alzheimersdisease https://www.bizjournals.com/boston/news/2019/12/26/as-2019-closes-out-these-are-the-local-drugs-and.html?ana=e_mc_prem&j=90421661&t=Niche&mkt_tok=eyJpIjoiTkRFM1lqazRNakU1TXprMCIsInQiOiJJMlpyRkhlMTZmcDZJYlRzcXJoTWhkamUrSENFUXhFaytlOGdcLytpQzZDYVZiK2ZFclhtRHpJblFscHJVNjE5cTNyOG80RGlHNmVJanZcL0RjTGhJeEUxa2NxSDM2ZWk3WUE2bkltdStsWUpSMnYwSXFcL00yV3ZxMTUwZFl2bkNuQiJ9#g/465220/12 …pic.twitter.com/XEwCcftMeB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are thrilled to celebrate the news of the CENTAUR study topline results with the
#ALS community. Thank you for your tremendous support and encouragement. Stay tuned for more updates in 2020!https://bwnews.pr/2tnbQwpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On the morning of the CENTAUR study topline results announcement, advocates from
@iamalsorg took over Times Square to raise awareness of the need to develop new treatments for#ALS and other neurodegenerative diseases. Today’s events are a reminder that together, we can#EndALSpic.twitter.com/hZLngjY7M9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@jonathanrockoff for helping us share this exciting news. People with#ALS have no time to lose, so we're moving as quickly as possible to submit detailed results from the CENTAUR study for peer-reviewed publication and presentation at a future medical congress.https://twitter.com/jonathanrockoff/status/1206908182595035136 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amylyx proslijedio/la je Tweet
If its promising data hold up when released in full, the ALS drug from Amylyx Pharmaceuticals could lead a wave of new treatments for the progressive, fatal diseasehttps://on.wsj.com/2tpVMu1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amylyx proslijedio/la je Tweet
Amylyx drug helps slow ALS progression in mid-stage studyhttps://reut.rs/2S1Pmva
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to announce the
@CentaurStudy topline results today. Thank you to the participants and their families, clinics and groups who supported this trial. We're encouraged and incredibly eager to press ahead in the fight for people with#ALS#endALShttps://bwnews.pr/2tnbQwpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We’ve taken a closer look at how far we’ve come with an exciting trial underway, all of which is possible thanks to those fighting relentlessly alongside us," shared Dr. Patrick Yeramian via
@TheADDF's Alzheimer's Matters Blog. Read more here: http://bit.ly/2EafqfsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Welcome to the team, Deb. We're looking forward to continuing to build a culture geared toward improving the lives of those suffering from disease. https://bwnews.pr/2Ehm2Zv pic.twitter.com/hJcD8UQ189
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our deepest condolences to the Frates family, we've lost a true hero today. But Pete’s spirit and ability to bring people together will continue to inspire and drive the fight for new treatments.
#ALSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today and every day let's celebrate and honor those who have served our nation in the armed forces. Thank you for your service and courage.
#VeteransDayHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Earlier this month,
@CentaurStudy in#ALS completed its last-patient/ last-visit. Amylyx is currently working feverishly to complete analysis and share results. Read more, as told by@PracticalNeurol, herehttp://bit.ly/36bj05UHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In a recent interview with
@PracticalNeurol, cofounder@justin_klee and@CentaurStudy PI@PaganoniMDPhD discussed Amylyx' mission to do right by patients if this trial is a success and the impact of a partnership between industry and academia. Read more:http://bit.ly/36bj05UHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to
@CentaurStudy Principal Investigator@PaganoniMDPhD on this incredible recognition for all of your efforts in the#ALS community.#AANEMhttps://twitter.com/MGHNeurology/status/1184465738335019011 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The last
@CentaurStudy participant has completed the planned 24 weeks of study treatment! We’re working quickly to share data with the#ALS Community in the next few months#NeurodegenerativeDiseaseshttps://bwnews.pr/2VfKW3nHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re thrilled to announce the last
@CentaurStudy participant has completed the planned 24 weeks of study treatment. "Thank you to the participants and site study teams who have made this work possible,” said Principle Investigator,@PaganoniMDPhD.#ALShttps://bwnews.pr/2VfKW3nHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today at
#NEALS19, Principal Investigator of@CentaurStudy,@PaganoniMDPhD, presented the novel features and design of the#ALS clinical trial. We’re proud to share nearly 90% of participants have elected to continue into the open label extension#NeurodegenerativeDiseasespic.twitter.com/nepUFwSNSx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@bsw5020 for all of the wonderful things you do for pALS and the#ALS community - you inspire us every day@iamalsorghttps://twitter.com/bsw5020/status/1179789227258712069 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.